{"id":407,"date":"2019-11-03T20:27:10","date_gmt":"2019-11-03T18:27:10","guid":{"rendered":"http:\/\/cratia.com\/?post_type=countries&#038;p=407"},"modified":"2020-11-18T17:17:44","modified_gmt":"2020-11-18T15:17:44","slug":"registracziya-lekarstvennyh-sredstv","status":"publish","type":"countries","link":"https:\/\/cratia.com\/en\/countries\/kyrgyzstan\/registracziya-lekarstvennyh-sredstv\/","title":{"rendered":"Registration of medicines"},"content":{"rendered":"<p><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">According to the Law of the Kyrgyz Republic \u201cOn medicinal products\u201d, import and sale of medicinal products in Kyrgyzstan are only allowed after state registration (renewal of registration).<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Registration of medicinal products may be performed by the decision of Applicant either under the \u201cnational\u201d procedure until 31 December 2020, or under the \u201cuniform\u201d EAEU procedure; and only under the \u201cuniform\u201d procedure of the EAEU after 31 December 2020.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Competent authority responsible for expert evaluation of registration materials for finished medicinal products is the Department of pharmaceutical supply and medical equipment of the Ministry of Health of the Kyrgyz Republic (website: <\/span><a href=\"http:\/\/www.pharm.kg\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">http:\/\/www.pharm.kg\/<\/span><\/a><span style=\"font-weight: 400;\">).\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The procedure for national registration is described below. For <a href=\"\/en\/countries\/evrazijskij-ekonomicheskij-soyuz\/registracziya-lekarstvennyh-sredstv\/\">description and requirements of the \u201ccentralized\u201d EAEU procedure please follow the link<\/a>.\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\">\n<p style=\"text-align: justify;\"><b>National registration procedure\u00a0<\/b><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The procedure for national state registration of medicinal products was approved by Resolution of the Government of the Kyrgyz Republic No. 405 dated August 28, 2018. It is also necessary to take into account the provisions of Technical Regulation &#8220;On the safety of medicinal products for medical use&#8221;, approved by Resolution of the Government of the Kyrgyz Republic No. 137 dated April 6, 2011 (updated December 6, 2018).<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The registration dossier is accepted in the CTD format. For a complete registration dossier, it is necessary to develop specific national documents:<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Application form;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Normative document (ND) &#8211; regulatory document that includes the composition of the finished product, specification for release and shelf life, quality control methods, information on storage conditions, information on the manufacturers, etc.;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Instructions for medical use (package insert);\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Color artworks (mock-ups) of the primary and secondary packaging.\u00a0<\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Part of the documentation must be submitted with translation into Russian.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">For orphan drugs, it is allowed to submit a summary of preclinical and clinical data, with a rationale for the benefit-risk ratio, instead of preclinical and clinical materials.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The registration dossier is submitted in electronic form, except:<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Module 1 (administrative data);<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Normative document (ND);\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Instructions for medical use of a medicinal product (package leaflet).<\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Module 1 must be submitted considering the requirements for international legalization of documents.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The package labeling is submitted and approved in Russian and\/or Kyrgyz.\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Instructions for medical use should be submitted and approved in Russian and Kyrgyz.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Stages of the registration procedure in brief:<\/span><\/p>\n<ol style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Filling the Application form and registration materials;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Submission of the documentation and samples to the competent authority;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Payment of the state fees;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Expert evaluation (primary and secondary) of the registration materials;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Answers on the deficiency letters, corrections and reconciliation of the text of the instructions, normative document and package labeling;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Laboratory control of the samples;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Positive conclusion of the specialized assessment;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Ministry of Health issues the Order on state registration of the medicinal product;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Registration certificate is granted to the MAH.\u00a0<\/span><\/li>\n<\/ol>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Laboratory quality control of finished product is required. MAH should provide samples and reference standards in quantity sufficient to perform QC in 3 parallels.\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Timeline of the registration is 180 calendar days from submission of the Application and registration dossier. This period does not include the time necessary for the MAH to pay state fees, the duration of the laboratory analysis and the time for responses to questions (observations). In some cases, the inspection of the manufacturing site and quality assurance system is required.<\/span><\/p>\n<p style=\"text-align: justify;\">\n<p style=\"text-align: justify;\"><b>Inspection of the manufacturing site<\/b><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Inspection of the manufacturing site is carried out at the newly introduced manufacturing site, as well as in case of transfer of manufacturing technologies (for generic medicinal products).<\/span><\/p>\n<p style=\"text-align: justify;\">\n<p style=\"text-align: justify;\"><b>Language and labeling<\/b><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The package labeling is submitted and approved in Russian and\/or Kyrgyz.\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Instructions for medical use should be submitted in Russian, approved in Russian and Kyrgyz.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Kyrgyzstan is a country with high standards of regulation of marketed medicinal products. Inconsistencies between approved and actual packaging layouts, instructions for use, quality certificates may cause rejection of the medicinal product and temporary or permanent prohibition on sales.<\/span><\/p>\n<p style=\"text-align: justify;\">\n<p style=\"text-align: justify;\"><b>The Registration Certificate<\/b><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The Registration Certificate consists of several documents:<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Registration Certificate itself;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Approved text of the instructions for medical use;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Approved color artworks (mock-ups) of the primary and secondary packaging;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Approved normative document on control of the quality of medicinal product.<\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The validity period of the Registration certificate is 5 years. The Registration Certificate is issued in the name of the Applicant (Marketing Authorization Holder) of the registration, which can be either a resident or non-resident of the Kyrgyz Republic.<\/span><\/p>\n<p style=\"text-align: justify;\">\n<p style=\"text-align: justify;\"><b>Changes and variations\u00a0<\/b><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Variations to the Registration Certificate are performed on the basis of Resolution of the Government of the Kyrgyz Republic No. 137 on the approval of Technical Regulation &#8220;On the safety of medicinal products for medical use&#8221; dated April 6, 2011 and Procedure for state registration of medicinal products for medical use approved by Resolution of the Government of the Kyrgyz Republic No. 405 dated August 28, 2018.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The owner (Marketing Authorization Holder) of the Registration certificate for medicinal product is obliged to inform the competent state authority of any changes regarding the authorised medicinal product data submitted during registration, providing comprehensive information about the reasons for these changes and their possible impact on the efficacy, safety and quality of the medicinal product.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Changes that do not require new registration procedure:<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Change in the name without changing the composition;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Change in the name of the manufacturer;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Change in the legal address, details of the manufacturer or holder of the registration certificate without changing the manufacturing site;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Change in the composition and quantity of excipients (except for components of vaccines and biological medicinal products) in order to improve the quality parameters of the medicinal product;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Change in the qualitative composition of the primary (immediate) packaging of the medicinal product;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Addition of new warning(s) or limitations of therapeutic indicators during the medical use of a medicinal product to the instruction for medical use;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Change of the prescription status of the medicinal product;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Addition or replacement of a measuring device for oral liquid dosage forms and other dosage forms of the medicinal product;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Change of organization of the manufacturer(s) of the active substance, addition of a new manufacturer organization(s) of the active substance;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Change of Normative document on quality of the medicinal product;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Change in the shelf life of the medicinal product in relation to the period specified during registration;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Change in the shelf life of the medicinal product after the packaging has been opened for the first time;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Change of dimensions of tablets, capsules, suppositories or pessaries without change in qualitative composition of ingredients and mean mass;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Changes in the manufacturing process for components requiring a test procedure for new impurities.\u00a0<\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The period of specialized expert evaluation of the variations procedure is 60 business days, not including the time for responses to observations (deficiencies).\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\">\n<p style=\"text-align: justify;\"><b>Renewal of registration (confirmation of registration)<\/b><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The Application for renewal must be submitted no earlier than 180 calendar days before the expiration of the Registration Certificate validity, but no later than the last day of the Registration Certificate validity.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Medicinal products placed on the market of Kyrgyzstan within the validity of the registration certificate are allowed for sale until the expiration date.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The following documentation is required for renewal of registration:\u00a0<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Module 1;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Module 2;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">PSUR;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Normative document on quality;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">A copy of the valid Registration certificate.<\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The period of specialized expert evaluation of the renewal procedure is 50 business days, not including the time for responses to observations (deficiencies).\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Positive decision on the renewal grants Registration certificate without expiry.\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\">\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\"><strong>Cratia provides professional services of state registration (renewals, variations) of medicinal products in Kyrgyzstan. We have an excellent knowledge of national legislation, necessary experience and resources.<\/strong>\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">To start cooperation or get advice, please contact us by phone: +38 068 064-78-31, +38 044 223-61-67, by e-mail: <a href=\"mailto:info@cratia.ua\">info@cratia.ua<\/a>, or visit <a href=\"\/en\/contacts\/\">our office<\/a>.\u00a0<\/span><\/p>","protected":false},"featured_media":0,"parent":144,"menu_order":1,"template":"","class_list":["post-407","countries","type-countries","status-publish","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/cratia.com\/en\/wp-json\/wp\/v2\/countries\/407","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cratia.com\/en\/wp-json\/wp\/v2\/countries"}],"about":[{"href":"https:\/\/cratia.com\/en\/wp-json\/wp\/v2\/types\/countries"}],"up":[{"embeddable":true,"href":"https:\/\/cratia.com\/en\/wp-json\/wp\/v2\/countries\/144"}],"wp:attachment":[{"href":"https:\/\/cratia.com\/en\/wp-json\/wp\/v2\/media?parent=407"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}